Isonicotinic Acid Vanillylidenehydrazide is primarily utilized in the field of medicinal chemistry due to its potential therapeutic properties. It is studied for its antimicrobial activity, particularly against tuberculosis-causing bacteria, as it is structurally related to isoniazid, a well-known anti-tuberculosis drug. Researchers explore its efficacy in inhibiting bacterial growth and its potential as a treatment option for drug-resistant strains of tuberculosis.

Additionally, this compound is investigated for its antioxidant properties, which may help in reducing oxidative stress in biological systems. Its ability to scavenge free radicals makes it a candidate for further research in combating oxidative damage-related diseases, such as neurodegenerative disorders and cardiovascular conditions.

In the realm of material science, Isonicotinic Acid Vanillylidenehydrazide is also examined for its potential use in the development of organic semiconductors and photonic materials. Its unique chemical structure allows for the creation of stable and efficient materials for electronic devices, including sensors and light-emitting diodes (LEDs).

Overall, this compound holds promise in both biomedical and technological applications, making it a subject of ongoing research and development.